在美国制药行业的支持下,美国政府打算让人们接受这种说法,即美国人之所以支付较高的药价,是因为他们承担了过高的研发成本,而这部分研发成本超出了他们应该承担的份额。本文的两位研究者从证据出发,认为事实并非如此。美国政府正在进行一个运动,把美国高昂的药品价格和新药发 With the support of the U.S. pharmaceutical industry, the U.S. government intends to let people accept that Americans pay higher drug prices because they have assumed excessive R&D costs, and this part of R&D costs exceeds what they should Take share. The two researchers of this paper proceed from the evidence and believe that this is not the case. The U.S. government is conducting a campaign to send high drug prices and new drugs in the U.S.